Access cutting-edge chronic lymphocytic leukemia treatment through this clinical trial at a research site in Sarasota. Study-provided care at no cost to qualified participants.
Access chronic lymphocytic leukemia specialists in Sarasota at no cost
This study follows strict safety protocols and ethical guidelines
All study-related chronic lymphocytic leukemia treatment provided free
Study J2N-MC-JZ01 (JZ01) is an individual-study appendix (ISA) under master protocol J2N-MC-JZNY, and represents participants from the completed originator study, clinical study LOXO-BTK-18001/J2N-OX-JZNA. Participants in the originator study will have the opportunity to continue their assigned study intervention or continue their follow-up visits by transitioning to this study. This study will evaluate the long-term safety and efficacy of pirtobrutinib.
Sponsor: Eli Lilly and Company
Check if you qualify for this chronic lymphocytic leukemia clinical trial in Sarasota, FL
If you're searching for chronic lymphocytic leukemia treatment options in Sarasota, FL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Sarasota research site is actively enrolling participants for this clinical trial. You'll receive care from experienced chronic lymphocytic leukemia specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.